Maze Therapeutics, Inc. ($MAZE)
Filing Information
| Accession Number | 0002050172-26-000019 |
|---|---|
| Form Type | 4 |
| Filing Date | Apr 2, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
45,000
Total Value
$598,204.24
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
President, R&D & CMO | Common Stock | โ | Apr 1, 2026 | Exercise/Conversion | 15,000 | $10.42 | $156,300.00 | 15,000 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Apr 1, 2026 | Sale | 11,352 | $29.24 | $331,948.37 | 3,648 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Apr 1, 2026 | Sale | 3,348 | $30.06 | $100,635.86 | 300 | Direct | โ | View Details | |
President, R&D & CMO | Common Stock | โ | Apr 1, 2026 | Sale | 300 | $31.07 | $9,320.01 | 0 | Direct | โ | View Details | |
President, R&D & CMO | Stock Option (Right to Buy) | Derivative | Apr 1, 2026 | Exercise/Conversion | 15,000 | $0.00 | $0.00 | 237,407 | Direct | โ | View Details |